These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 32595253)
1. VERIFICATION OF AUTHENTICITY OF Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253 [No Abstract] [Full Text] [Related]
2. An effective identification and quantification method for Ginkgo biloba flavonol glycosides with targeted evaluation of adulterated products. Ma YC; Mani A; Cai Y; Thomson J; Ma J; Peudru F; Chen S; Luo M; Zhang J; Chapman RG; Shi ZT Phytomedicine; 2016 Apr; 23(4):377-87. PubMed ID: 27002408 [TBL] [Abstract][Full Text] [Related]
3. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558 [TBL] [Abstract][Full Text] [Related]
4. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. van Beek TA; Montoro P J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661 [TBL] [Abstract][Full Text] [Related]
5. Identification of Ginkgo biloba supplements adulteration using high performance thin layer chromatography and ultra high performance liquid chromatography-diode array detector-quadrupole time of flight-mass spectrometry. Avula B; Sagi S; Gafner S; Upton R; Wang YH; Wang M; Khan IA Anal Bioanal Chem; 2015 Oct; 407(25):7733-46. PubMed ID: 26297458 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a method to determine flavonol aglycones in Ginkgo biloba dietary supplement crude materials and finished products by high-performance liquid chromatography: collaborative study. Gray D; LeVanseler K; Meide P; Waysek EH J AOAC Int; 2007; 90(1):43-53. PubMed ID: 17373435 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells. Lin H; Guo X; Zhang S; Dial SL; Guo L; Manjanatha MG; Moore MM; Mei N Toxicol Sci; 2014 Jun; 139(2):338-49. PubMed ID: 24595819 [TBL] [Abstract][Full Text] [Related]
8. A sensitive and selective multiple reaction monitoring mass spectrometry method for simultaneous quantification of flavonol glycoside, terpene lactones, and biflavonoids in Ginkgo biloba leaves. Wang LT; Fan XH; Jian Y; Dong MZ; Yang Q; Meng D; Fu YJ J Pharm Biomed Anal; 2019 Jun; 170():335-340. PubMed ID: 30986686 [TBL] [Abstract][Full Text] [Related]
9. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats. Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034 [TBL] [Abstract][Full Text] [Related]
10. [Determination of flavonoids in Ginkgo biloba L. leaves from different producing areas]. Wang H; Zhao GB; Liu SQ; Zheng JH Zhongguo Zhong Yao Za Zhi; 2000 Jul; 25(7):408-10. PubMed ID: 12515221 [TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric imaging of flavonoid glycosides and biflavonoids in Ginkgo biloba L. Beck S; Stengel J Phytochemistry; 2016 Oct; 130():201-6. PubMed ID: 27233155 [TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Chen ZP; Sun J; Chen HX; Xiao YY; Liu D; Chen J; Cai H; Cai BC Fitoterapia; 2010 Dec; 81(8):1045-52. PubMed ID: 20603197 [TBL] [Abstract][Full Text] [Related]
14. Coumaroyl flavonol glycosides from the leaves of Ginkgo biloba. Tang Y; Lou F; Wang J; Li Y; Zhuang S Phytochemistry; 2001 Dec; 58(8):1251-6. PubMed ID: 11738417 [TBL] [Abstract][Full Text] [Related]
15. Differences in in vivo absorption of flavone glycosides, flavone aglycones and terpene lactones under different dosage forms and physiological conditions. Luo J; Ren H; Ye J; Wang X; Li P; Bai J; Lu Y; Du S J Ethnopharmacol; 2023 Apr; 306():116159. PubMed ID: 36649852 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous quantification of terpenelactones and flavonol aglycones in hydrolyzed ginkgo biloba extract by liquid chromatography with inline ultraviolet and evaporative light scattering detection. Gray DE; Messer D; Porter A; Ferguson S; Harris RK; Clark AP; Algaier JW; Overstreet JD; Smith CS J AOAC Int; 2005; 88(6):1613-20. PubMed ID: 16526440 [TBL] [Abstract][Full Text] [Related]
17. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1. Chang TK; Chen J; Yeung EY Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive HPTLC fingerprinting as a tool for a simplified analysis of purity of ginkgo products. Frommenwiler DA; Booker A; Vila R; Heinrich M; Reich E; Cañigueral S J Ethnopharmacol; 2019 Oct; 243():112084. PubMed ID: 31306695 [TBL] [Abstract][Full Text] [Related]
19. HPLC-UV/HRMS methods for the unambiguous detection of adulterations of Bampali E; Germer S; Bauer R; Kulić Ž Pharm Biol; 2021 Dec; 59(1):438-443. PubMed ID: 33886418 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols. Lau AJ; Chang TK Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]